Manidipine is not a potential inhibitor against SARS-CoV-2 main protease
Abstract
Substances (4)
Materials
| Procduct Name | CAS | Molecular Formula | Supplier | Price |
| Paxlovid | 2628280-40-8 | C23H32F3N5O4 | 302 suppliers | Inquiry |
| Paxlovid | 2628280-40-8 | C23H32F3N5O4 | 302 suppliers | Inquiry |
| Manidipine | 89226-50-6 | C35H38N4O6 | 149 suppliers | $49.00-$1750.00 |
| Manidipine | 89226-50-6 | C35H38N4O6 | 149 suppliers | $49.00-$1750.00 |
Similar articles
IF:6.8
Antiviral efficacy of selective estrogen receptor modulators against SARS-CoV-2 infection in vitro and in vivo reveals bazedoxifene acetate as an entry inhibitor
Journal of Medical Virology
Gen Miao, Haoran Peng,etc
Published: 22 June 2022
IF:96.2
A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection.
New England Journal of Medicine
M Markowitz, M Saag,etc
Published: 7 December 1995
IF:3.2
3-Hydroxyacetophenone in carnations is a phytoanticipin active against Fusarium oxysporum f. sp. dianthi
Phytochemistry
Paolo Curir , Augusto Marchesini ,etc
Published: 1 February 1996
Latest Papers
In vitro and in vivo activity of 1,2,3,4,6-O-pentagalloyl-glucose against Candida albicans
Published: 5 March 2025
LC-AMP-I1, a novel venom-derived antimicrobial peptide from the wolf spider Lycosa coelestis
Published: 2 December 2024
Manidipine is not a potential inhibitor against SARS-CoV-2 main protease
Published: 6 March 2024